SAWO ONCOLOGY GmbH is a Switzerland based consultancy company specialising in clinical development (phase I–III) and medical affairs services in internal medicine, haematology, palliative care, and oncology for hospitals and clients developing immunology-based, cell therapies (incl. CAR-T cells, MSCs, placenta and cord blood stem cells),

Over 32 years of experience. and small molecules for targeted therapy throughout the world. 

SAWO ONCOLOGY GmbH is managed by Professor Wolfram Dempke (fully qualified and board certified in internal medicine and haematology, haemostasiology and oncology: over 32 years experience).

Major services provided by SAWO ONCOLOGY GmbH include, but are not limited to: 

• Development of clinical and marketing strategies
• Product development and life-cycle management plans
• Preparation of clinical documentation (including eCTD) (broad experience)
• Preparation of NDAs for EMA and FDA submission (broad experience)
• Due diligence of business opportunities including negotiations with payers
• Medial writing and preparing of launch activities
• Expert’s advice for any type of planned or ongoing medical treatment

      (internal medicine, haematology, oncology, palliative care) (“second opinion”)

• University lecturing, invited lectures, Sales Reps and MSL training programmes
• Oncology and Palliative Care Nursing
• Deputyship for clinics and office-based clinicians (“Honorararzt”)

SAWO ONCOLOGY GmbH offers a unique bundle of scientific, medical, medical marketing, and nursing knowledge with hands-on experience covering all relevant aspects of drug development providing an outstanding service in a flexible but timely manner since our patients and clients cannot afford to wait for the promise of tomorrow as long as progress can be made with tools at hand today.

Modern equipment and trained specialists. We attach great importance to a personal relationship with our clients.